Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM)

Journal of Human Hypertension

Volumn 10, Issue 2, 1996, Pages 123-127

  Oren, S ^a   Turkot, S ^a   Paran, E ^b   Flandra, O ^b   Slezak, L ^c   Hof, B ^d  

^a BARZILAI MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Lin Clinic   (Israel)

^d Teva Pharmaceutical Industry ^*  (Israel)

Author keywords

Essential hypertension; Insulin resistance; NIDDM; Urapidil

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; POSTSYNAPTIC RECEPTOR; SEROTONIN RECEPTOR; URAPIDIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEADACHE; HEART PALPITATION; HEART RATE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; SITTING; SLEEP DISORDER; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VERTIGO; XEROSTOMIA;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE DETERMINATION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PIPERAZINES; TREATMENT OUTCOME;

EID: 0029985408     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Modan M et al. Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 800-817.
2. De Fronzo RH, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Mogensen CE, Hansen KW. Preventing and postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention. Contrib Nephrol 1990; 78: 73-100.
5. Knowler WC, Bennet PW, Ballantine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 1980; 302: 645-650.
6. Gall MA et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin dependent) diabetic patients. Diabetologia 1991; 34: 655-661.
7. Grimm RH et al. Effects of thiazide diabetes on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med 1981; 94: 7-11.
8. Tuck M. Treatment of hypertensive diabetic patients. Diabetes Care 1988; 11: 828-832.
9. Schmitz O et al. Insulin action in insulin dependent diabetics after short-term thiazide therapy. Diabetes Care 1986; 9: 631-636.
10. De Fronzo RA et al. Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest 1984; 73: 633-639.
11. Astrup A et al. Epinephrine mediates facultative carbohydrate-induced thermogenesis in human skeletal muscle. Am J Physiol 1984; 257 (Suppl): E340-345.
12. Ferrari P, Rosman J, Weidmann P. Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol 1991; 67: 26B-35B.
13. Rett K et al. Role of angiotensin converting enzyme in non-insulin dependent diabetes mellitus. Postgrad Med J 1988; 64: 69-73.
14. Jauch KW et al. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur J Clin Invest 1987; 17: 448-454.
15. Torlone E et al. ACE inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34: 119-125.
16. Bak PF, Gerdes LV, Sorenson N, Pedersen O. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients. Am J Med 1992; 92 (Suppl 4B): 69S-72S.
17. Trost BN, Weidman P. Metabolic effects of calcium antagonists in humans with emphasis on carbohydrate, lipid, potassium and uric acid homeostasis. J Cardiovasc Pharmacol 1988; 12 (Suppl 6): S86-S92.
18. Chellingsworth MC et al. The effects of verapamil, diltiazem, nifedipine and propranolol on metabolic control in hypertensives with non-insulin dependent diabetic mellitus. J Hum Hypertens 1989; 3: 35-39.
19. Feher MD et al. Alpha-blocker therapy, a possible advance in the treatment of diabetic hypertension - results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non insulin dependent diabetic subjects. J Hum Hypertens 1990; 4: 571-577.
20. Taylor SH. Efficacy of doxazocin in specific hypertensive patient groups. Am Heart J 1991; 121: 286-292.
21. Lehtonen A. Doxazocin effects on insulin and glucose in hypertensive patients. Am Heart J 1991; 121: 1307-1311.
22. 1-adrenergic blocking agents. J Clin Pharmacol 1993; 33: 2-13.
23. Gerber A et al. Cardiovascular and metabolic profile during intervention with urapidil in humans. Hypertension 1985; 7: 963-971.
24. Lithell HO, Pollare T, Berne C. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharmacol 1990; 15 (Suppl 5): S46-S52.
25. Eriksson KF, Lindgarde F. Contribution of estimated resistance and glucose intolerance to essential hypertension. J Intern Med 1991; 229 (Suppl 2): 75-83.
26. Grimm RH. Lipid effects of antihypertensive agents: an overview. Choices Cardiol 1988; 2: 208-210.
27. Houston MC. The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetes. Am Heart J 1988; 115: 640-656.
28. Pollare T, Lithell H, Selinus I, Bene C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988; 31: 415-420.
29. Swislicki ALM et al. Effects of prazosin treatment on carbohydrate and lipoprotien metabolism in patients with hypertension. Am J Med 1989; 86: 14-18.
30. Fariello R et al. Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus. Eur Heart J 1992; 13 (Suppl A): 65-59.
31. Lieban H, Sollider P, Wurst W. Long-term antihypertensive treatment with urapidil. Curr Opinion Cardiol 1984; 4 (Suppl 4): S57-S62.
32. Leonetti G et al. Influence of urapidil and other antihypertensive agents on lipid and glucose metabolism in hypertensive patients. Eur Heart J 1992; 13 (Suppl A): 61-64.